Diet only and diet plus simvastatin in the treatment of heterozygous familial hypercholesterolemia in childhood

Drugs under Experimental and Clinical Research

Volumn 25, Issue 1, 1999, Pages 23-28

  Stefanutti, Claudio ^a,b   Lucani, G ^a   Vivenzio, A ^a   Di Giacomo, S ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BEZAFIBRATE; CHOLESTEROL; COLESTIPOL; COLESTYRAMINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PROBUCOL; SIMVASTATIN; SITOSTEROL;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; DIET THERAPY; ECHOCARDIOGRAPHY; EXERCISE ELECTROCARDIOGRAPHY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HETEROZYGOSITY; HUMAN; MALE; SCHOOL CHILD;

ANTICHOLESTEREMIC AGENTS; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET, FAT-RESTRICTED; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HETEROZYGOTE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; SIMVASTATIN;

EID: 0032942123     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Strong I.P., Me Gill H.C., Jr. The pediatric aspects of atherosclerosis. J. Ather. Res., 9(3), 251, 1969.
2. Haitas B., Baker S.G., Meyer T.E., Joffe B.I., Seftel H.C. Natural history and cardiac manifestations of homozygous familial hypercholesterolemia. Quarterly J. Med., 76(279), 731, 1990.
3. Neufeld E.J. Inherited dyslipidemias in childhood. Curr. Opin. Pediatr., 5(6), 707, 1993.
4. Newman W.P., Freedman D.S., Voors A.W., Berenson G. Serum lipoproteins and systolic blood pressure are related to atherosclerosis in early life: The Bogalusa Heart Study. N. Engl. J. Med., 314, 138, 1986.
5. Laue L., Hoeg J.M., Barnes K., Ross J.L., Loriax D.L., Chrousos G.P. Abnormal growth hormone secretory dynamics in children with familial hypercholesterolemia. Horm. Res., 29(1), 23, 1988.
6. Stary H.C. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Artheriosclerosis, 9 (Suppl.), 1189, 1989.
7. Kwiterovich P.O., Jr. Pediatric implications of heterozygous familial hypercholesterolemia. Artheriosclerosis, 9(1) Suppl., 1111, 1989.
8. Glassman M., Spark A., Berezin S., Schwarz S., Medow M., Newman L.J. Treatment of type IIa hyperlipidemia in childhood by a simplified American Heart Association diet and fiber supplementation. Am. J. Dis. Child, 144(9), 973, 1990.
9. Horiguchi Y., Yamamoto A., Kamita T., Arakaki Y., Fujita T. Cardiovascular finding in familial hypercholesterolemic children. Jap. Circul. J., 55(2), 142, 1991.
10. Heine W., Hernel O., Koletzko B., et al. Committee report: childhood diet and prevention of coronary heart disease. ESPGAN Committee on Nutrition. European Society of Pediatric Gastroenterology and Nutrition. J. Pediatr. Gastroenterol. Nutr., 19(3), 261, 1994.
11. Williams C.L., Bollella M. Guidelines for screening, evaluating, and treating children with hypercholesterolemia. J. Pediatr. Health Care, 9(4), 153, 1995.
12. Stein E.A. Treatment of familial hypercholesterolemia with drug in children. Artheriosclerosis, 9(1) (Suppl.), 1145, 1989.
13. Boucherle A., Calop J. Rossignol A.M., Bost M. Treatment of essential hypercholesterolemia by normolipemic drugs in children. Pediatric., 44(8), 633, 1939.
14. Pyörälä K., De Backer G., Graham I., Poole-Wilson P., Wood D., on behalf of the task force. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur. Heart J., 15, 1300, 1994.
15. Lifshitz F., Moses N. A complication of dietary treatment of hypercholesterolemia. Am. J. Dis. Child, 143, 537, 1989.
16. Laurin D., Jacques M., Moorjani S., et al. Effects of a soy-protein beverage on plasma lipoproteins in children with familial hypercholesterolemia. Am. J. Clin. Nutr., 54(1), 98, 1991.
17. Gylling H., Siimes M.A., Miettinen T.A. Sitostanol ester margarine in dietary treatment of children with familial hypercholesterolemia. J. Lipid Res., 36(8), 1807, 1995.
18. Sansujurjo P., Martul P., Sasieta M., Lafuente P., Ariza F., Cabeza L. Treatment with probucol of children with familial hypercholesterolemia. Acta Paed, Scand., 77(1), 132, 1988.
19. Uauy R., Vega G.L., Grundy S,M., Bilheimer D.M. Lovastatin therapy in receptor-negative homozygous familial hypercholesterolemia: lack of effect on LDL concentrations or turnover. J. Clin. End. Metab., 113(2), 387, 1988.
20. Becker M., Staad D., Von Bergman K. Long-term treatment of severe familial hypercholesterolemia in children: effect of sitosterol and bezafibrate. Pediatrics, 89(1), 138, 1992.
21. Summary of the second report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II). J.A.M.A., 269, 23, 1993.
22. Lambert M., Lupien P.J., Gagn C., Levy E., Blaichman S. Treatment of familial hypercholesterolemia in children and adolescents: effect of Lovastatin. Canadian Lovastatin in Children Study Group. Pediatrics, 97(5), 619, 1996.
23. Tonstad S., Sivertsen M., Aksnes L., Ose L Low dose colestipol in adolescents with familial hypercholesterolemia. Arch. Dis. Child, 74(2), 157, 1996.